Four studies [31, 33, 35, 40] reported severe hypoglycaemia, with 3075 events observed among the 70,828 (4%) participants in the combination therapy group compared with 2284 events among the 72,657 (3%) participants in the monotherapy group (ESM Table 8)
In a study, people taking Wegovy 7.2 mg lost about 18% of their body weight over 72 weeks, and roughly one in three lost 25% or more
**Nausea and Vomiting**: These are the most common side effects, especially when starting the medication or increasing the dose
Its review standards closely align with the Federal Trade Commission (FTC) Act and FTC guidelines
2024;326(3):E26876
Research studies have shown that patients experience sustainable weight loss when using semaglutide for an extended period